Literature DB >> 28939693

Mass spectrometry techniques for studying the ubiquitin system.

Rachel E Heap1, Megan S Gant1, Frederic Lamoliatte1, Julien Peltier1, Matthias Trost2.   

Abstract

Post-translational control of proteins through covalent attachment of ubiquitin plays important roles in all eukaryotic cell functions. The ubiquitin system in humans consists of 2 E1, 35 E2 and >600 E3 ubiquitin ligases as well as hundreds of deubiquitylases, which reverse ubiquitin attachment. Moreover, there are hundreds of proteins with ubiquitin-binding domains that bind one of the eight possible polyubiquitin chains. Dysfunction of the ubiquitin system is associated with many diseases such as cancer, autoimmunity and neurodegeneration, demonstrating the importance of ubiquitylation. Therefore, enzymes of the ubiquitin system are considered highly attractive drug targets. In recent years, mass spectrometry (MS)-based techniques have become increasingly important in the deciphering of the ubiquitin system. This short review addresses the state-of-the-art MS techniques for the identification of ubiquitylated proteins and their ubiquitylation sites. We also discuss the identification and quantitation of ubiquitin chain topologies and highlight how the activity of enzymes in the ubiquitin pathway can be measured. Finally, we present current MS tools that can be used for drug discovery in the ubiquitin space.
© 2017 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.

Entities:  

Keywords:  SUMOylation; deubiquitylase; mass spectrometry; proteomics; signalling; ubiquitins

Mesh:

Substances:

Year:  2017        PMID: 28939693     DOI: 10.1042/BST20170091

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  15 in total

1.  Traumatic Brain Injury Temporal Proteome Guides KCC2-Targeted Therapy.

Authors:  Pavel N Lizhnyak; Pretal P Muldoon; Pallavi P Pilaka; John T Povlishock; Andrew K Ottens
Journal:  J Neurotrauma       Date:  2019-07-31       Impact factor: 5.269

2.  Thermal proteome profiling of breast cancer cells reveals proteasomal activation by CDK4/6 inhibitor palbociclib.

Authors:  Teemu P Miettinen; Julien Peltier; Anetta Härtlova; Marek Gierliński; Valerie M Jansen; Matthias Trost; Mikael Björklund
Journal:  EMBO J       Date:  2018-04-18       Impact factor: 11.598

Review 3.  Assays and technologies for developing proteolysis targeting chimera degraders.

Authors:  Xingui Liu; Xuan Zhang; Dongwen Lv; Yaxia Yuan; Guangrong Zheng; Daohong Zhou
Journal:  Future Med Chem       Date:  2020-05-20       Impact factor: 3.808

4.  Triggering MSR1 promotes JNK-mediated inflammation in IL-4-activated macrophages.

Authors:  Manman Guo; Anetta Härtlova; Marek Gierliński; Alan Prescott; Josep Castellvi; Javier Hernandez Losa; Sine K Petersen; Ulf A Wenzel; Brian D Dill; Christoph H Emmerich; Santiago Ramon Y Cajal; David G Russell; Matthias Trost
Journal:  EMBO J       Date:  2019-04-26       Impact factor: 11.598

5.  The BioGRID interaction database: 2019 update.

Authors:  Rose Oughtred; Chris Stark; Bobby-Joe Breitkreutz; Jennifer Rust; Lorrie Boucher; Christie Chang; Nadine Kolas; Lara O'Donnell; Genie Leung; Rochelle McAdam; Frederick Zhang; Sonam Dolma; Andrew Willems; Jasmin Coulombe-Huntington; Andrew Chatr-Aryamontri; Kara Dolinski; Mike Tyers
Journal:  Nucleic Acids Res       Date:  2019-01-08       Impact factor: 16.971

6.  Ubiquitin and SUMO conjugation as biomarkers of acute myeloid leukemias response to chemotherapies.

Authors:  Pierre Gâtel; Frédérique Brockly; Christelle Reynes; Manuela Pastore; Yosr Hicheri; Guillaume Cartron; Marc Piechaczyk; Guillaume Bossis
Journal:  Life Sci Alliance       Date:  2020-04-17

7.  Ubiquitylomes Analysis of the Whole blood in Postmenopausal Osteoporosis Patients and healthy Postmenopausal Women.

Authors:  Yi-Ran Yang; Chun-Wen Li; Jun-Hua Wang; Xiao-Sheng Huang; Yi-Feng Yuan; Jiong Hu; Kang Liu; Bo-Cheng Liang; Zhong Liu; Xiao-Lin Shi
Journal:  Orthop Surg       Date:  2019-11-25       Impact factor: 2.071

Review 8.  Hybrid Chains: A Collaboration of Ubiquitin and Ubiquitin-Like Modifiers Introducing Cross-Functionality to the Ubiquitin Code.

Authors:  David A Pérez Berrocal; Katharina F Witting; Huib Ovaa; Monique P C Mulder
Journal:  Front Chem       Date:  2020-01-22       Impact factor: 5.221

9.  The MALDI-TOF E2/E3 Ligase Assay as Universal Tool for Drug Discovery in the Ubiquitin Pathway.

Authors:  Virginia De Cesare; Clare Johnson; Victoria Barlow; James Hastie; Axel Knebel; Matthias Trost
Journal:  Cell Chem Biol       Date:  2018-07-12       Impact factor: 8.116

Review 10.  Signal-Targeted Therapies and Resistance Mechanisms in Pancreatic Cancer: Future Developments Reside in Proteomics.

Authors:  Célia Cintas; Thibaut Douché; Nicole Therville; Silvia Arcucci; Fernanda Ramos-Delgado; Céline Basset; Benoît Thibault; Julie Guillermet-Guibert
Journal:  Cancers (Basel)       Date:  2018-06-01       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.